Amphastar Pharmaceuticals Cash Conversion Cycle 2011-2026 | AMPH

Annual Cash Conversion Cycle Amphastar Pharmaceuticals

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
166	159	173	170	198	215	139	179	192	168	206	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
215	139	179

Quarterly Cash Conversion Cycle Amphastar Pharmaceuticals

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
211	219	212	-	160	-	-	-	-	-	175	-	80.8	162	158	-	171	187	179	-	213	196	211	49.7	225	219	171	53.1	138	144	162	54.4	171	162	195	38.5	196	196	205	39.4	159	184	180	37.3	172	236	214	40.9	154	82.5	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
236	37.3	156

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
AgeX Therapeutics AGE	-8.96 K	-	-10.17 %	$ 12.2 K	USA
Adagene ADAG	53.8	$ 1.59	3.92 %	$ 89.5 M	China
Arrowhead Pharmaceuticals ARWR	8.75	$ 65.93	-	$ 8.82 B	USA
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Biogen BIIB	387	$ 185.63	-	$ 27 B	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
Bristol-Myers Squibb Company BMY	60.4	$ 55.77	-	$ 113 B	USA
AstraZeneca PLC AZN	-58	$ 93.63	-	$ 96.9 B	Britain
BeiGene, Ltd. BGNE	49.5	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	6.09	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	214	-	-7.31 %	$ 87 M	USA
Catalyst Biosciences CBIO	391	$ 10.98	1.76 %	$ 723 M	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Coherus BioSciences CHRS	326	$ 1.65	-	$ 155 M	USA
Celldex Therapeutics CLDX	-6.08 K	$ 25.67	-	$ 1.65 M	USA
Cellectis S.A. CLLS	-839	$ 4.26	-	$ 116 M	France
Caladrius Biosciences CLBS	164	-	-16.75 %	$ 25.8 M	USA
Clearside Biomedical CLSD	-1.67 K	-	-	$ 25.3 M	USA
Chimerix CMRX	588	-	-	$ 756 M	USA
Corcept Therapeutics Incorporated CORT	-186	$ 37.36	-0.37 %	$ 3.86 B	USA
Catalyst Pharmaceuticals CPRX	54.2	$ 23.22	-	$ 2.75 B	USA
Adaptimmune Therapeutics plc ADAP	25	-	-15.15 %	$ 60.3 M	Britain
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	-1.55 K	-	-0.23 %	$ 916 M	USA
Crinetics Pharmaceuticals CRNX	2 K	$ 55.35	3.94 %	$ 4.47 B	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
CRISPR Therapeutics AG CRSP	1.1 K	$ 55.3	-	$ 4.67 B	Schweiz
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
Ampio Pharmaceuticals AMPE	-2.85 K	-	-11.43 %	$ 502 K	USA